Resting energy expenditure and glucose, protein and fat oxidation in severe chronic virus hepatitis B patients

Table 1 Clinical characteristics of the patients

Group	n	Age (yr)	Male/Female	ALT (U/L)	AST (U/L)	T-Bil (mg/dL)	ALB (g/L)	PA (g/L)	CHE (g/L)	CH (g/L)
1	16	34 ± 16	10/6	154.3 ± 184.8	68.3 ± 58.4	4.4 ± 6.4	36.6 ± 4.4	142.0 ± 66.0	6050.9 ± 2243.6	164.9 ± 49.4
2	56	46 ± 13	49/9	189.2 ± 374.9	156.8 ± 159.4	20.4 ± 9.8	29.8 ± 4.6	52.5 ± 27.5	2723.6 ± 1422.2	52.3 ± 36.2
3	28	53 ± 10	24/4	68.3 ± 118.9	80.2 ± 80.6	5.8 ± 7.2	29.5 ± 7.2	62.2 ± 34	2628.6 ± 1416.3	114.9 ± 42.7

Group 1: Acute hepatitis group; Group 2: Chronic severe hepatitis group; Group 3: Cirrhosis group. PTA: Prothrombin activity. PTA = (control PT-8.7)/(patients PT-8.7) × 100%.